Entry - #618239 - MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17 - OMIM
# 618239

MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
8q22.1 Mitochondrial complex I deficiency, nuclear type 17 618239 AR 3 NDUFAF6 612392
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
SKELETAL
Spine
- Scoliosis
Feet
- Flat feet
MUSCLE, SOFT TISSUES
- Hypotonia
- Muscle atrophy
NEUROLOGIC
Central Nervous System
- Normal early development (in some patients)
- Developmental regression (in some patients)
- Loss of motor skills (in some patients)
- Developmental delay
- Gait difficulties
- Dystonia
- Dysarthria
- Rigidity
- Ataxia
- Seizures (in some patients)
- White matter abnormalities consistent with Leigh syndrome
METABOLIC FEATURES
- Lactic acidosis
LABORATORY ABNORMALITIES
- Increased serum lactate
- Mitochondrial respiratory complex I deficiency in various tissues
MISCELLANEOUS
- Onset in infancy or early childhood
- Variable severity
MOLECULAR BASIS
- Caused by mutation in the NADH-ubiquinone oxidoreductase complex assembly factor 6 gene (NDUFAF6, 612392.0001)
Mitochondrial complex I deficiency, nuclear type - PS252010 - 39 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1q23.3 Mitochondrial complex I deficiency, nuclear type 6 AR 3 618228 NDUFS2 602985
2q33.1 Mitochondrial complex I deficiency, nuclear type 25 AR 3 618246 NDUFB3 603839
2q33.3 Mitochondrial complex I deficiency, nuclear type 5 AR 3 618226 NDUFS1 157655
2q37.3 Mitochondrial complex I deficiency, nuclear type 22 AR 3 618243 NDUFA10 603835
3p21.31 Mitochondrial complex I deficiency, nuclear type 18 AR 3 618240 NDUFAF3 612911
3q13.33 Mitochondrial complex I deficiency, nuclear type 31 AR 3 618251 TIMMDC1 615534
3q21.3 Mitochondrial complex I deficiency, nuclear type 20 AR 3 611126 ACAD9 611103
5p15.33 Mitochondrial complex I deficiency, nuclear type 9 AR 3 618232 NDUFS6 603848
5q11.2 Mitochondrial complex I deficiency, nuclear type 1 AR 3 252010 NDUFS4 602694
5q12.1 Mitochondrial complex I deficiency, nuclear type 10 AR 3 618233 NDUFAF2 609653
5q31.3 Mitochondrial complex I deficiency, nuclear type 13 AR 3 618235 NDUFA2 602137
6q16.1 Mitochondrial complex I deficiency, nuclear type 15 AR 3 618237 NDUFAF4 611776
7q11.23 Leber-like hereditary optic neuropathy, autosomal recessive 1 AR 3 619382 DNAJC30 618202
8q22.1 Mitochondrial complex I deficiency, nuclear type 17 AR 3 618239 NDUFAF6 612392
8q24.13 ?Mitochondrial complex I deficiency, nuclear type 24 AR 3 618245 NDUFB9 601445
9q33.2 Mitochondrial complex I deficiency, nuclear type 37 AR 3 619272 NDUFA8 603359
10q24.31 Mitochondrial complex I deficiency, nuclear type 32 AR 3 618252 NDUFB8 602140
11p11.2 Mitochondrial complex I deficiency, nuclear type 8 AR 3 618230 NDUFS3 603846
11q13.2 Mitochondrial complex I deficiency, nuclear type 4 AR 3 618225 NDUFV1 161015
11q13.2 Mitochondrial complex I deficiency, nuclear type 2 AR 3 618222 NDUFS8 602141
11q14.1 Mitochondrial complex I deficiency, nuclear type 36 AR 3 619170 NDUFC2 603845
11q14.1 Mitochondrial complex I deficiency, nuclear type 29 AR 3 618250 TMEM126B 615533
11q24.2 Mitochondrial complex I deficiency, nuclear type 19 AR 3 618241 FOXRED1 613622
12p13.32 Mitochondrial complex I deficiency, nuclear type 26 AR 3 618247 NDUFA9 603834
12q22 Mitochondrial complex I deficiency, nuclear type 23 AR 3 618244 NDUFA12 614530
14q12 Mitochondrial complex I deficiency, nuclear type 21 AR 3 618242 NUBPL 613621
15q15.1 Mitochondrial complex I deficiency, nuclear type 11 AR 3 618234 NDUFAF1 606934
15q22.31 Mitochondrial complex I deficiency, nuclear type 27 AR 3 618248 MTFMT 611766
16p13.3 ?Mitochondrial complex I deficiency, nuclear type 35 AR 3 619003 NDUFB10 603843
17q25.3 Mitochondrial complex I deficiency, nuclear type 34 AR 3 618776 NDUFAF8 618461
18p11.22 Mitochondrial complex I deficiency, nuclear type 7 AR 3 618229 NDUFV2 600532
19p13.3 Mitochondrial complex I deficiency, nuclear type 3 AR 3 618224 NDUFS7 601825
19p13.3 Mitochondrial complex I deficiency, nuclear type 14 AR 3 618236 NDUFA11 612638
19p13.12 ?Mitochondrial complex I deficiency, nuclear type 39 AR 3 620135 NDUFB7 603842
19p13.11 ?Mitochondrial complex I deficiency, nuclear type 28 AR 3 618249 NDUFA13 609435
20p12.1 Mitochondrial complex I deficiency, nuclear type 16 AR 3 618238 NDUFAF5 612360
22q13.2 Mitochondrial complex I deficiency, nuclear type 33 AR 3 618253 NDUFA6 602138
Xp11.3 ?Mitochondrial complex I deficiency, nuclear type 30 XL 3 301021 NDUFB11 300403
Xq24 Mitochondrial complex I deficiency, nuclear type 12 XLR 3 301020 NDUFA1 300078

TEXT

A number sign (#) is used with this entry because of evidence that mitochondrial complex I deficiency nuclear type 17 (MC1DN17) is caused by homozygous or compound heterozygous mutation in the NDUFAF6 gene (612392) on chromosome 8q22.

For a discussion of genetic heterogeneity of mitochondrial complex I deficiency, see 252010.


Clinical Features

Pagliarini et al. (2008) reported 2 Lebanese sibs, born of consanguineous parents, who presented in infancy with focal seizures, decreased movement and strength, ataxia, lactic acidosis, and neuroimaging results consistent with Leigh syndrome. Biochemical studies showed complex I deficiency in liver, muscle, and fibroblasts.

Bianciardi et al. (2016) reported a 7-year-old boy, born of unrelated parents, with mitochondrial complex I deficiency and Leigh syndrome. After normal early development, the patient presented at 3.5 years of age with progressive gait and speech difficulties, dystonic movements, loss of fine motor abilities, and signal alterations in the brain affecting the caudate and putamina; he was unable to walk at age 7 years, but verbal comprehension appeared to be preserved.

Kohda et al. (2016) reported 4 unrelated children with mitochondrial complex I deficiency and Leigh syndrome. Clinical details were limited.

Catania et al. (2018) reported 4 patients from 3 families with MC1DN17, including the patient previously described by Bianciardi et al. (2016). Two affected sibs had normal early development, but presented with psychomotor abnormalities at 21 and 12 months of age. Brain MRI showed bilateral T2-hyperintensities in the caudate and putamen in 1 sib, and bilateral T2-hyperintensities in the dentate nucleus and superior cerebellar peduncles in the other. Cognitive impairment was spared in both sibs. The fourth patient presented at 5 years of age with gait and coordination abnormalities, which progressed to include extrapyramidal symptoms. Brain MRI at 7 years of age showed bilateral T2-hyperintense signals in the putamen.

Baide-Mairena et al. (2019) described 3 Spanish sibs with MC1DN17. Early developmental milestones were normal, and all 3 sibs walked between 12 and 15 months of age. Neurologic abnormalities presented between 17 months and 2.5 years and progressed to generalized dystonia, loss of ambulation, and significant oromandibular and bulbar involvement. No acute encephalopathic episodes occurred. In 2 of the sibs, plasma amino acids, lactate, and urine organic acids were normal; these were not tested in the third sib. MRI showed caudate and putamen abnormalities in 2 sibs, and only putamen abnormalities in the third. MR spectroscopy in 1 sib showed a lactate peak in the caudate and putamen. Nerve conduction studies in 1 sib showed a peripheral demyelinating neuropathy.

Johnstone et al. (2020) reported a 27-year-old man (proband B) with MC1DN17. At age 4 years, he and his 3-year-old sister developed neurologic symptoms, including tiptoeing and dystonia, 4 weeks after experiencing high fever in the setting of a viral illness. A brain MRI in the brother showed cavitary lesions of the putamina. At age 27 years, he had normal cognition but was significantly impaired by generalized dystonia. He had no additional episodes of acute neurologic or metabolic decompensation after the original episode. No clinical follow-up of the sister was provided.


Molecular Genetics

In 2 Lebanese sibs, born of consanguineous parents, with mitochondrial complex I deficiency nuclear type 17 and Leigh syndrome, Pagliarini et al. (2008) identified a homozygous missense mutation in the NDUFAF6 gene (Q99R; 612392.0001) substitution in a highly conserved residue. The mutation was not present in 100 control Lebanese chromosomes.

In a 7-year-old boy, born of unrelated parents, with complex I deficiency and Leigh syndrome, Bianciardi et al. (2016) identified a heterozygous mutation in the NDUFAF6 gene (A178P; 612392.0002). The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, was inherited from the unaffected father. A second pathogenic variant affecting the NDUFAF6 gene was not identified. Analysis of patient cells excluded nonsense-mediated mRNA decay as well as alterations in methylation of the NDUFAF6 promoter. Patient fibroblasts, but not skeletal muscle, showed decreased complex I activity and decreased assembly of complex I, which could be rescued by overexpression of wildtype NDUFAF6. RNA analysis showed an almost mono-allelic expression of the mutated allele in blood and fibroblasts from the patient, whereas there was biallelic expression in urine and buccal mucosa. Blood and fibroblasts from the father showed biallelic expression. Bianciardi et al. (2016) suggested that the second mutational event in the NDUFAF6 gene may be postmeiotic, affecting a nonexonic regulatory element and explaining the different tissue-specific expression, or that it may affect a specific protein

In 4 children from 3 southern Italian families with MC1DN17 manifesting as Leigh syndrome, including the patient reported by Bianciardi et al. (2016), Catania et al. (2018) identified compound heterozygosity for mutations in the NDUFAF6 gene: A178P (612392.0002) and a splice site mutation (612392.0009). Haplotype analysis showed that all 4 patients shared the same haplotype in the NDUFAF6 genomic region, indicating that they likely have common NDUFAF6 alleles rather than independent mutational events.

In 4 unrelated children with mitochondrial complex I deficiency and Leigh syndrome, Kohda et al. (2016) identified biallelic missense mutations in the NDUFAF6 gene (612392.0003-612392.0007). The mutations, which were found by high-throughput exome sequencing of 142 unrelated patients with childhood-onset mitochondrial respiratory chain complex deficiencies, segregated with the disorder in the families.

In 3 Spanish sibs with MC1DN17 manifesting as Leigh syndrome, Baide-Mairena et al. (2019) identified compound heterozygous missense mutations in the NDUFAF6 gene: I124T (612392.0005) and a 5-bp deletion (612392.0010). The mutations, which were found by next-generation sequencing of a Leigh syndrome-focused gene panel, were validated by Sanger sequencing. Studies in fibroblasts of one of the sibs showed decreased mitochondrial ATP, NDUFAF6 mRNA and protein expression, mitochondrial complex I expression, and complex I activity via in-gel activity staining. Studies in muscle homogenates from 2 of the sibs showed decreased mitochondrial complex I activity by in-gel activity staining compared to control. Transduction of wildtype NDUFAF6 into patient fibroblasts rescued complex I assembly and in-gel activity.

In a Hispanic brother (proband B) and sister with MC1DN17 manifesting as mild Leigh syndrome, Johnstone et al. (2020) identified compound heterozygous mutations in the NDUFAF6 gene (612392.0005 and 612392.0011). The mutations, which were identified by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family.


REFERENCES

  1. Baide-Mairena, H., Gaudo, P., Marti-Sanchez, L., Emperador, S., Sanchez-Montanez, A., Alonso-Luengo, O., Correa, M., Grau, A. M., Ortigoza-Escobar, J. D., Artuch, R., Vazquez, E., Del Toro, M., Garrido-Perez, N., Ruiz-Pesini, E., Montoya, J., Bayona-Bafaluy, M. P., Perez-Duenas, B. Mutations in the mitochondrial complex I assembly factor NDUFAF6 cause isolated bilateral striatal necrosis and progressive dystonia in childhood. Molec. Genet. Metab. 126: 250-258, 2019. [PubMed: 30642748, related citations] [Full Text]

  2. Bianciardi, L., Imperatore, V., Fernandez-Vizarra, E., Lopomo, A., Falabella, M., Furini, S., Galluzzi, P., Grosso, S., Zeviani, M., Renieri, A., Mari, F., Frullanti, E. Exome sequencing coupled with mRNA analysis identifies NDUFAF6 as a Leigh gene. Molec. Genet. Metab. 119: 214-222, 2016. [PubMed: 27623250, related citations] [Full Text]

  3. Catania, A., Ardissone, A., Verrigni, D., Legati, A., Reyes, A., Lamantea, E., Diodato, D., Tonduti, D., Imperatore, V., Pinto, A. M., Moroni, I., Bertini, E., Robinson, A., Carrozzo, R., Zeviani, M., Ghezzi, D. Compound heterozygous missense and deep intronic variants in NDUFAF6 unraveled by exome sequencing and mRNA analysis. J. Hum. Genet. 63: 563-568, 2018. [PubMed: 29531337, related citations] [Full Text]

  4. Johnstone, T., Wang, J., Ross, D., Balanda, N., Huang, Y., Godfrey, R., Groden, C., Barton, B. R., Gahl, W., Toro, C., Malicdan, M. C. V. Biallelic variants in two complex I genes cause abnormal splicing defects in probands with mild Leigh syndrome. Molec. Genet. Metab. 131: 98-106, 2020. [PubMed: 33097395, related citations] [Full Text]

  5. Kohda, M., Tokuzawa, Y., Kishita, Y., Nyuzuki, H., Moriyama, Y., Mizuno, Y., Hirata, T., Yatsuka, Y., Yamashita-Sugahara, Y., Nakachi, Y., Kato, H., Okuda, A., and 23 others. A comprehensive genomic analysis reveals the genetic landscape of mitochondrial respiratory chain complex deficiencies. PLoS Genet. 12: e1005679, 2016. Note: Electronic Article. [PubMed: 26741492, related citations] [Full Text]

  6. Pagliarini, D. J., Calvo, S. E., Chang, B., Sheth, S. A., Vafai, S. B., Ong, S.-E., Walford, G. A., Sugiana, C., Boneh, A., Chen, W. K., Hill, D. E., Vidal, M., Evans, J. G., Thorburn, D. R., Carr, S. A., Mootha, V. K. A mitochondrial protein compendium elucidates complex I disease biology. Cell 134: 112-123, 2008. [PubMed: 18614015, related citations] [Full Text]


Hilary J. Vernon - updated : 04/15/2021
Hilary J. Vernon - updated : 06/22/2020
Creation Date:
Cassandra L. Kniffin : 12/10/2018
carol : 04/15/2021
carol : 06/23/2020
carol : 06/22/2020
carol : 01/30/2019
ckniffin : 01/18/2019
carol : 12/13/2018

# 618239

MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17


ORPHA: 255241;   DO: 0112078;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
8q22.1 Mitochondrial complex I deficiency, nuclear type 17 618239 Autosomal recessive 3 NDUFAF6 612392

TEXT

A number sign (#) is used with this entry because of evidence that mitochondrial complex I deficiency nuclear type 17 (MC1DN17) is caused by homozygous or compound heterozygous mutation in the NDUFAF6 gene (612392) on chromosome 8q22.

For a discussion of genetic heterogeneity of mitochondrial complex I deficiency, see 252010.


Clinical Features

Pagliarini et al. (2008) reported 2 Lebanese sibs, born of consanguineous parents, who presented in infancy with focal seizures, decreased movement and strength, ataxia, lactic acidosis, and neuroimaging results consistent with Leigh syndrome. Biochemical studies showed complex I deficiency in liver, muscle, and fibroblasts.

Bianciardi et al. (2016) reported a 7-year-old boy, born of unrelated parents, with mitochondrial complex I deficiency and Leigh syndrome. After normal early development, the patient presented at 3.5 years of age with progressive gait and speech difficulties, dystonic movements, loss of fine motor abilities, and signal alterations in the brain affecting the caudate and putamina; he was unable to walk at age 7 years, but verbal comprehension appeared to be preserved.

Kohda et al. (2016) reported 4 unrelated children with mitochondrial complex I deficiency and Leigh syndrome. Clinical details were limited.

Catania et al. (2018) reported 4 patients from 3 families with MC1DN17, including the patient previously described by Bianciardi et al. (2016). Two affected sibs had normal early development, but presented with psychomotor abnormalities at 21 and 12 months of age. Brain MRI showed bilateral T2-hyperintensities in the caudate and putamen in 1 sib, and bilateral T2-hyperintensities in the dentate nucleus and superior cerebellar peduncles in the other. Cognitive impairment was spared in both sibs. The fourth patient presented at 5 years of age with gait and coordination abnormalities, which progressed to include extrapyramidal symptoms. Brain MRI at 7 years of age showed bilateral T2-hyperintense signals in the putamen.

Baide-Mairena et al. (2019) described 3 Spanish sibs with MC1DN17. Early developmental milestones were normal, and all 3 sibs walked between 12 and 15 months of age. Neurologic abnormalities presented between 17 months and 2.5 years and progressed to generalized dystonia, loss of ambulation, and significant oromandibular and bulbar involvement. No acute encephalopathic episodes occurred. In 2 of the sibs, plasma amino acids, lactate, and urine organic acids were normal; these were not tested in the third sib. MRI showed caudate and putamen abnormalities in 2 sibs, and only putamen abnormalities in the third. MR spectroscopy in 1 sib showed a lactate peak in the caudate and putamen. Nerve conduction studies in 1 sib showed a peripheral demyelinating neuropathy.

Johnstone et al. (2020) reported a 27-year-old man (proband B) with MC1DN17. At age 4 years, he and his 3-year-old sister developed neurologic symptoms, including tiptoeing and dystonia, 4 weeks after experiencing high fever in the setting of a viral illness. A brain MRI in the brother showed cavitary lesions of the putamina. At age 27 years, he had normal cognition but was significantly impaired by generalized dystonia. He had no additional episodes of acute neurologic or metabolic decompensation after the original episode. No clinical follow-up of the sister was provided.


Molecular Genetics

In 2 Lebanese sibs, born of consanguineous parents, with mitochondrial complex I deficiency nuclear type 17 and Leigh syndrome, Pagliarini et al. (2008) identified a homozygous missense mutation in the NDUFAF6 gene (Q99R; 612392.0001) substitution in a highly conserved residue. The mutation was not present in 100 control Lebanese chromosomes.

In a 7-year-old boy, born of unrelated parents, with complex I deficiency and Leigh syndrome, Bianciardi et al. (2016) identified a heterozygous mutation in the NDUFAF6 gene (A178P; 612392.0002). The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, was inherited from the unaffected father. A second pathogenic variant affecting the NDUFAF6 gene was not identified. Analysis of patient cells excluded nonsense-mediated mRNA decay as well as alterations in methylation of the NDUFAF6 promoter. Patient fibroblasts, but not skeletal muscle, showed decreased complex I activity and decreased assembly of complex I, which could be rescued by overexpression of wildtype NDUFAF6. RNA analysis showed an almost mono-allelic expression of the mutated allele in blood and fibroblasts from the patient, whereas there was biallelic expression in urine and buccal mucosa. Blood and fibroblasts from the father showed biallelic expression. Bianciardi et al. (2016) suggested that the second mutational event in the NDUFAF6 gene may be postmeiotic, affecting a nonexonic regulatory element and explaining the different tissue-specific expression, or that it may affect a specific protein

In 4 children from 3 southern Italian families with MC1DN17 manifesting as Leigh syndrome, including the patient reported by Bianciardi et al. (2016), Catania et al. (2018) identified compound heterozygosity for mutations in the NDUFAF6 gene: A178P (612392.0002) and a splice site mutation (612392.0009). Haplotype analysis showed that all 4 patients shared the same haplotype in the NDUFAF6 genomic region, indicating that they likely have common NDUFAF6 alleles rather than independent mutational events.

In 4 unrelated children with mitochondrial complex I deficiency and Leigh syndrome, Kohda et al. (2016) identified biallelic missense mutations in the NDUFAF6 gene (612392.0003-612392.0007). The mutations, which were found by high-throughput exome sequencing of 142 unrelated patients with childhood-onset mitochondrial respiratory chain complex deficiencies, segregated with the disorder in the families.

In 3 Spanish sibs with MC1DN17 manifesting as Leigh syndrome, Baide-Mairena et al. (2019) identified compound heterozygous missense mutations in the NDUFAF6 gene: I124T (612392.0005) and a 5-bp deletion (612392.0010). The mutations, which were found by next-generation sequencing of a Leigh syndrome-focused gene panel, were validated by Sanger sequencing. Studies in fibroblasts of one of the sibs showed decreased mitochondrial ATP, NDUFAF6 mRNA and protein expression, mitochondrial complex I expression, and complex I activity via in-gel activity staining. Studies in muscle homogenates from 2 of the sibs showed decreased mitochondrial complex I activity by in-gel activity staining compared to control. Transduction of wildtype NDUFAF6 into patient fibroblasts rescued complex I assembly and in-gel activity.

In a Hispanic brother (proband B) and sister with MC1DN17 manifesting as mild Leigh syndrome, Johnstone et al. (2020) identified compound heterozygous mutations in the NDUFAF6 gene (612392.0005 and 612392.0011). The mutations, which were identified by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family.


REFERENCES

  1. Baide-Mairena, H., Gaudo, P., Marti-Sanchez, L., Emperador, S., Sanchez-Montanez, A., Alonso-Luengo, O., Correa, M., Grau, A. M., Ortigoza-Escobar, J. D., Artuch, R., Vazquez, E., Del Toro, M., Garrido-Perez, N., Ruiz-Pesini, E., Montoya, J., Bayona-Bafaluy, M. P., Perez-Duenas, B. Mutations in the mitochondrial complex I assembly factor NDUFAF6 cause isolated bilateral striatal necrosis and progressive dystonia in childhood. Molec. Genet. Metab. 126: 250-258, 2019. [PubMed: 30642748] [Full Text: https://doi.org/10.1016/j.ymgme.2019.01.001]

  2. Bianciardi, L., Imperatore, V., Fernandez-Vizarra, E., Lopomo, A., Falabella, M., Furini, S., Galluzzi, P., Grosso, S., Zeviani, M., Renieri, A., Mari, F., Frullanti, E. Exome sequencing coupled with mRNA analysis identifies NDUFAF6 as a Leigh gene. Molec. Genet. Metab. 119: 214-222, 2016. [PubMed: 27623250] [Full Text: https://doi.org/10.1016/j.ymgme.2016.09.001]

  3. Catania, A., Ardissone, A., Verrigni, D., Legati, A., Reyes, A., Lamantea, E., Diodato, D., Tonduti, D., Imperatore, V., Pinto, A. M., Moroni, I., Bertini, E., Robinson, A., Carrozzo, R., Zeviani, M., Ghezzi, D. Compound heterozygous missense and deep intronic variants in NDUFAF6 unraveled by exome sequencing and mRNA analysis. J. Hum. Genet. 63: 563-568, 2018. [PubMed: 29531337] [Full Text: https://doi.org/10.1038/s10038-018-0423-1]

  4. Johnstone, T., Wang, J., Ross, D., Balanda, N., Huang, Y., Godfrey, R., Groden, C., Barton, B. R., Gahl, W., Toro, C., Malicdan, M. C. V. Biallelic variants in two complex I genes cause abnormal splicing defects in probands with mild Leigh syndrome. Molec. Genet. Metab. 131: 98-106, 2020. [PubMed: 33097395] [Full Text: https://doi.org/10.1016/j.ymgme.2020.09.008]

  5. Kohda, M., Tokuzawa, Y., Kishita, Y., Nyuzuki, H., Moriyama, Y., Mizuno, Y., Hirata, T., Yatsuka, Y., Yamashita-Sugahara, Y., Nakachi, Y., Kato, H., Okuda, A., and 23 others. A comprehensive genomic analysis reveals the genetic landscape of mitochondrial respiratory chain complex deficiencies. PLoS Genet. 12: e1005679, 2016. Note: Electronic Article. [PubMed: 26741492] [Full Text: https://doi.org/10.1371/journal.pgen.1005679]

  6. Pagliarini, D. J., Calvo, S. E., Chang, B., Sheth, S. A., Vafai, S. B., Ong, S.-E., Walford, G. A., Sugiana, C., Boneh, A., Chen, W. K., Hill, D. E., Vidal, M., Evans, J. G., Thorburn, D. R., Carr, S. A., Mootha, V. K. A mitochondrial protein compendium elucidates complex I disease biology. Cell 134: 112-123, 2008. [PubMed: 18614015] [Full Text: https://doi.org/10.1016/j.cell.2008.06.016]


Contributors:
Hilary J. Vernon - updated : 04/15/2021
Hilary J. Vernon - updated : 06/22/2020

Creation Date:
Cassandra L. Kniffin : 12/10/2018

Edit History:
carol : 04/15/2021
carol : 06/23/2020
carol : 06/22/2020
carol : 01/30/2019
ckniffin : 01/18/2019
carol : 12/13/2018